<unk>  is an anticholinergic that is FDA approved for the treatment of for use as adjunctive therapy in the treatment of peptic ulcer..   Common adverse reactions include xerostomia; decreased sweating; urinary hesitancy and retention; blurred vision; tachycardia; palpitations; dilatation of the pupil; cycloplegia; increased ocular tension; loss of taste; headaches; nervousness; mental confusion; drowsiness; weakness; dizziness; insomnia; nausea; vomiting; constipation; bloated feeling; impotence; suppression of lactation.
Glycopyrronium bromide
Methscopolamine bromide
Bethanechol chloride
Cyclobenzaprine hydrochloride
Cimetropium bromide
Nomifensine
Glycopyrrolate 
Methylscopolamine